转移性HER-2阳性乳腺癌(MBC)放射完全缓解(rCR)后停止长期含曲妥珠单抗治疗安全吗?

M. Calamac, N. Stanic, O. Djurmez, M. Dimitrijević, J. Vukosavljević, K. Serovic, J. Oblakovic-Babic, I. Minić, I. Božović-Spasojević
{"title":"转移性HER-2阳性乳腺癌(MBC)放射完全缓解(rCR)后停止长期含曲妥珠单抗治疗安全吗?","authors":"M. Calamac, N. Stanic, O. Djurmez, M. Dimitrijević, J. Vukosavljević, K. Serovic, J. Oblakovic-Babic, I. Minić, I. Božović-Spasojević","doi":"10.1016/s0960-9776(23)00406-x","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":22301,"journal":{"name":"The Breast : Official Journal of the European Society of Mastology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P288 Is it safe to discontinue long-term trastuzumab containing therapy after radiological complete response (rCR) in metastatic HER-2 positive breast cancer (MBC)?\",\"authors\":\"M. Calamac, N. Stanic, O. Djurmez, M. Dimitrijević, J. Vukosavljević, K. Serovic, J. Oblakovic-Babic, I. Minić, I. Božović-Spasojević\",\"doi\":\"10.1016/s0960-9776(23)00406-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":22301,\"journal\":{\"name\":\"The Breast : Official Journal of the European Society of Mastology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Breast : Official Journal of the European Society of Mastology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s0960-9776(23)00406-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Breast : Official Journal of the European Society of Mastology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0960-9776(23)00406-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
P288 Is it safe to discontinue long-term trastuzumab containing therapy after radiological complete response (rCR) in metastatic HER-2 positive breast cancer (MBC)?
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
P160 Clinical significance of low-level HER2 expression breast cancer and its clinicopathological features: an analysis of 3547 breast cancer patients P062 Clinico-pathological presentation and peculiar challenges of breast cancer in patients aged less than 40 years [Young Breast Cancer (YBC)]: An experience from a tertiary center of a developing nation P097 Hypofractionated radiotherapy after neoadjuvant chemotherapy in Breast Cancer: Safety, feasibility, and early outcomes P124 The Study of subtype conversion after neoadjuvant chemotherapy in locally advance breast cancer P264 The Comparison Outcome of Implant-based Breast Reconstruction with ADM, Non-ADM and TiLOOP Reconstruction in Breast Cancer Patients: A Case Series
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1